Evidence map›Paper›PMID 37371992›Full record

ReviewAntioxidants (Basel, Switzerland)2023

Blueberry Supplementation and Skin Health.

John Ivarsson, Alessandra Pecorelli, Mary Ann Lila, Giuseppe Valacchi

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

John IvarssonPlants for Human Health Institute, Department of Food, Bioprocessing, and Nutrition Sciences, North Carolina State University, Kannapolis, NC 28081, USA.ORCID 0009-0003-2533-877X
Alessandra PecorelliDepartment of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-5207-068X
Mary Ann LilaPlants for Human Health Institute, Department of Food, Bioprocessing, and Nutrition Sciences, North Carolina State University, Kannapolis, NC 28081, USA.ORCID 0000-0002-4928-3836
Giuseppe ValacchiDepartment of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-8792-0947
North Carolina State University · USUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental stressors such as air pollutants, ozone, and UV radiation are among the most noxious outdoor stressors affecting human skin and leading to premature skin aging. To prevent the extrinsic aging, the skin is equipped with an effective defensive system. However, cutaneous defense mechanisms can be overwhelmed through chronic exposure to environmental pollutants. Recent studies have suggested that the topical usage of natural compounds, such as blueberries, could be a good strategy to prevent skin damage from the environment. Indeed, blueberries contain bioactive compounds found to induce an active skin response against the environmental noxious effects. In this review, results from recent studies on this topic are discussed in order to build the argument for blueberries to possibly be an effective agent for skin health. In addition, we hope to highlight the need for further research to elucidate the mechanisms behind the use of both topical application and dietary supplementation with blueberries to bolster cutaneous systems and defensive mechanisms.

Indexed as

antioxidantblueberriesinflammationpolyphenolskin

Identifiers

PMID37371992
PMCPMC10295438
OpenAlexW4380632851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.